drugset / Trial / NCT01813656

An Study of Aripiprazole in the Treatment of Methamphetamine Dependence

NCT01813656 ↗

Phase 4 Terminated 10 enrolled Wei Hao
RandomizedParallel-groupDouble-blindTreatment

Summary

Methamphetamine substance use is common worldwide. No approved pharmacologic treatments for methamphetamine dependence exist. Aripiprazole are Second generation antipsychotics,but have different pharmacological effects of neurotransmitters.To determine whether mirtazapine would reduce methamphetamine use among mehtamphetamine addicts.

Timeline

Start
2012-09
Primary completion
2013-12
Completion
2014-02

Outcome

Outcome not reported

Stopped: “Aripiprazole arm had obvious adverse reactions,especially akathisia.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 10 mg —